A new study from a small biotech firm shows scientists can use embryonic stem cells to create a pancreas tissue capable of producing insulin for treating Type 1 diabetes. The research at California-based Novocell has focused on converting the cells into pancreatic beta cells to produce insulin.

Full Story:

Related Summaries